钆塞酸增强MRI中的短暂性肝脏强化差异:肝胆期低信号观察的另一原因
回顾性分析125例钆塞酸增强MRI上出现短暂性肝脏强化差异的患者,其中20例(16%)在肝胆期呈低信号。单因素分析显示与楔形形态、大小≥21 mm、T2WI高信号、扩散受限及既往治疗相关;多因素分析显示与既往治疗、T2WI高信号及大小≥21 mm相关。12例有随访的患者中9例病灶缩小。
要点
- 短暂性肝脏强化差异在钆塞酸增强MRI肝胆期可表现为低信号,发生率16%(20/125)。
- 肝胆期低信号的短暂性肝脏强化差异多与大小≥21 mm、T2WI高信号及既往治疗相关。
- 随访中多数(9/12)肝胆期低信号的短暂性肝脏强化差异病灶缩小。
核心结论
- 钆塞酸增强MRI肝胆期表现为低信号的短暂性肝脏强化差异并不少见,随访中可能缩小,且更可能与大小≥21 mm、T2WI高信号及邻近肿瘤既往治疗相关。
研究设计与样本
- 回顾性研究,纳入125例(男91例,女34例)钆塞酸增强MRI上存在短暂性肝脏强化差异的患者,由3名阅片者定性及定量评估MRI特征及随访演变。
关键影像表现/征象
- 短暂性肝脏强化差异在肝胆期呈低信号者20/125例(16%)。
- 单因素分析显示肝胆期低信号与楔形形态(p < 0.001)、大小≥21 mm(p < 0.001)、T2WI高信号(p < 0.001)、扩散受限(p < 0.001)及既往治疗(p < 0.005)相关。
- 多因素分析显示肝胆期低信号与既往治疗(p < 0.05)、T2WI高信号(p < 0.001)及大小≥21 mm(p < 0.001)相关。
- 12例肝胆期低信号的短暂性肝脏强化差异患者有随访MRI,其中9例病灶缩小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To retrospectively determine the frequency, natural history and factors associated with the presence of transient hepatic enhancement difference showing hypointensity on hepatobiliary phase images of gadoxetic acid-enhanced MRI.
MATERIALS AND METHODS: Gadoxetic acid-enhanced MRI of 125 patients (91 men; 34 women) with transient hepatic enhancement difference were retrospectively reviewed. Three readers qualitatively and quantitatively evaluated MR imaging features and evolution at follow up. The Chi-square test, Fisher's exact test and Kruskall-Wallis rank test were used for statistical analysis.
RESULTS: Transient hepatic enhancement difference were hypointense on hepatobiliary phase images in 20 of 125 cases (16%). At univariate analysis there was association with wedge-shape morphology (p < 0.001), size ≥21 mm (p < 0.001), hyperintensity on T2-weighted imaging (p < 0.001), restricted diffusion (p < 0.001) and previous treatment (p < 0.005). At multivariate analysis, the following factors were associated: previous treatment (p < 0.05), hyperintensity on T2-weighted imaging (p < 0.001) and size ≥21 mm (p < 0.001). Of 12 patients with hypointense transient hepatic enhancement difference on hepatobiliary phase images who had follow-up MRI, nine showed reduction in size.
CONCLUSION: Transient hepatic enhancement difference observations showing hypointensity on hepatobiliary phase images of gadoxetic acid-enhanced MRI are not infrequent and may shrink at follow-up. They are more likely associated with size ≥21 mm, hyperintensity on T2-weighted images and previous treatment of adjacent tumor.
引用
- Torrisi C, Picone D, Cabibbo G, et al. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase. Eur J Radiol. 2018. PMID: 30292271. doi:10.1016/j.ejrad.2018.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。